Back to Journals » Pharmacogenomics and Personalized Medicine » Volume 7

Role of brentuximab vedotin in the treatment of relapsed or refractory Hodgkin lymphoma

Total article views   HTML views PDF downloads Totals
12,115 Dovepress* 8,738+ 2,338 11,076
PubMed Central* 3,377 1,189 4,566
Totals 12,115 3,527 15,642
*Since 20 February 2014
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar